OSI SYSTEMS INC quarterly report, Q3 FY2024

OSI Systems, Inc. Form 10-Q Summary

Reporting period: Fiscal third quarter and nine months ended March 31, 2024. The filing is a fiscal 2024 Q3 report, despite the request metadata referencing 2023 Q3. Financial statements are unaudited and presented under U.S. GAAP.

Business Context

OSI Systems designs and manufactures specialized electronic systems and components for security and inspection, optoelectronics and electronics manufacturing, and healthcare applications. The Security division was the primary growth driver, supported by cargo, vehicle inspection, aviation, and checkpoint systems, including large international contracts awarded during fiscal 2023 and 2024.

Key Financial Metrics

Metric	Three Months Ended March 31	Nine Months Ended March 31
Net revenues	$405.4 million, up 33.8%	$1,057.9 million, up 22.1%
Gross profit	$136.1 million; 33.6% margin	$376.1 million; 35.6% margin
Income from operations	$51.4 million	$126.2 million
Net income	$34.0 million	$83.5 million
Diluted EPS	$1.95	$4.82
Operating cash flow	Not separately presented for the quarter	$(58.5) million

Quarterly revenue growth was concentrated in Security, which increased 60.0% to $286.0 million. Optoelectronics and Manufacturing declined 2.9% to $77.9 million, and Healthcare declined 5.5% to $41.5 million.
Nine-month Security revenue increased 42.6% to $700.6 million, while Optoelectronics and Manufacturing declined 3.4% to $236.2 million and Healthcare declined 7.6% to $121.1 million.
Nine-month gross margin improved from 33.2% to 35.6%, primarily due to favorable Security mix and operating scale. Quarterly gross margin declined from 34.3% to 33.6%, mainly because of weaker Optoelectronics and Manufacturing mix.
Quarterly operating expenses increased 22.0% to $84.7 million; nine-month operating expenses increased 19.3% to $249.9 million. SG&A and R&D increased, while restructuring charges declined year over year for the nine-month period.
Interest and other expense increased to $7.4 million for the quarter and $19.7 million for the nine months, reflecting higher borrowing levels and interest rates.
The effective tax rate was 22.6% for the quarter and 21.7% for the nine months, compared with 23.8% and 22.6%, respectively, in the prior-year periods.

Liquidity, Cash Flow, Debt and Capital Resources

Cash and cash equivalents were $101.4 million at March 31, 2024, compared with $76.8 million at June 30, 2023. Approximately 78% was held by foreign subsidiaries and subject to repatriation tax considerations.
Nine-month operating cash flow was negative $58.5 million, compared with positive $72.7 million in the prior-year period. The decline primarily reflected increases in accounts receivable and inventories associated with international Security contracts.
Nine-month investing cash outflow was $24.9 million, including $13.6 million of capital expenditures, $12.9 million for intangible and other assets, and $9.0 million for business acquisitions.
Nine-month financing cash inflow was $110.7 million, primarily from net borrowings used to fund contract-related working capital. No common stock was repurchased during the period.
At March 31, 2024, the company had $349.0 million outstanding under its revolving credit facility, $137.5 million under its term loan, and $54.5 million under foreign bank lines primarily supporting letters of credit. Revolving facility availability was $176.3 million after borrowings and letters of credit.
Total debt, including current and long-term portions, was approximately $488.4 million, excluding the separate presentation of certain foreign credit lines. The company was in compliance with its credit facility covenants.
Management stated that available cash, credit facilities, and anticipated operating cash flow should be sufficient for operational needs for the next 12 months and the foreseeable future.

Material Changes Versus the Prior Comparable Period

Revenue and profitability increased substantially, driven by Security division growth under major international contracts.
Net income increased 56.1% for the quarter and 69.0% for the nine-month period; diluted EPS increased from $1.27 to $1.95 for the quarter and from $2.88 to $4.82 year to date.
Despite higher earnings, operating cash flow deteriorated by $131.1 million year over year because of working-capital investment in receivables and inventories.
Accounts receivable increased to $503.8 million from $380.8 million, while inventories increased to $442.8 million from $338.0 million.
Unbilled revenue increased 178% to $241.1 million, and advances from customers increased 210% to $65.9 million, primarily reflecting contract timing and activity in the Security division.
Debt and interest costs remained elevated as the company financed contract-related working capital. Interest expense increased despite a $2.7 million year-to-date benefit from the interest-rate swap.
The company acquired a contract manufacturer for approximately $6.3 million in December 2023 and a radiation-detection technology provider for approximately $2.8 million plus potential contingent consideration of up to $3.6 million.

Guidance, Outlook, Risks and Unusual Items

The filing does not provide specific quantitative revenue, earnings, or margin guidance. Management expects available funds, credit facilities, and operating cash flow to support operations.
Remaining performance obligations were approximately $925.1 million at March 31, 2024; approximately 57% was expected to be recognized over the following 12 months.
Management cited risks from global economic uncertainty, inflation, interest rates, labor shortages, supply-chain and freight disruptions, tariffs and trade restrictions, foreign exchange, government procurement policies, cybersecurity, geopolitical conflicts, and healthcare customer financial pressure.
Three international Security contracts awarded during fiscal 2023 and 2024 had aggregate value exceeding $800 million, with revenue expected over multiple years. Execution, customer acceptance, delivery timing, and working-capital requirements remain important considerations.
Restructuring and other charges were $1.0 million in the quarter and $2.5 million for the nine months, including facility closures, employee terminations, acquisition-related costs, and legal charges.
A subsidiary received a follow-up Department of Justice subpoena in February 2024 concerning business dealings in Mexico and a former employee. The company is cooperating; no liability was accrued because an adverse loss was not considered probable and reasonably estimable.
Environmental matters and other legal proceedings could have a material adverse effect if resolved unfavorably, although management currently does not consider potential losses probable and reasonably estimable.
A $13.5 million contractual bonus to the Chief Executive Officer was paid in February 2024.
On April 29, 2024, amended employment agreements were executed with the CFO, General Counsel, and President of the OSI Cargo & Solutions Group. The agreements provide for base salaries, severance provisions, change-in-control protections, and potential equity acceleration.

Most Important Facts for Investors to Verify

Whether Security contract execution and customer acceptance support the reported revenue acceleration and the $925.1 million remaining performance obligation balance.
Whether receivables, unbilled revenue, and inventories convert to cash without material delays, write-downs, or collection losses.
The sustainability of improved gross margins as the sales mix and international contract volumes change.
Debt repayment capacity, revolver availability, covenant compliance, and sensitivity to interest rates.
The impact of foreign-currency movements, with approximately 78% of cash held by foreign subsidiaries.
Potential exposure from the Department of Justice subpoenas, environmental matters, other litigation, and contingent acquisition payments of up to $48.6 million.
Whether Healthcare and Optoelectronics and Manufacturing weakness persists and offsets continued Security growth.
Management’s subsequent fiscal 2024 guidance, which is not quantitatively provided in this filing.